0001179110-14-004580.txt : 20140305 0001179110-14-004580.hdr.sgml : 20140305 20140305190422 ACCESSION NUMBER: 0001179110-14-004580 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140303 FILED AS OF DATE: 20140305 DATE AS OF CHANGE: 20140305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vukovic Vojo CENTRAL INDEX KEY: 0001466794 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 14670944 MAIL ADDRESS: STREET 1: C/O SYNTA PHARMACEUTICALS CORP. STREET 2: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 edgar.xml FORM 4 - X0306 4 2014-03-03 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001466794 Vukovic Vojo C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 SVP, Chief Medical Officer Employee Stock Option (Right to Buy) 6.15 2014-03-03 4 A 0 141211 0 A 2024-03-03 Common Stock 141211 141211 D The option vests as to 25% of the shares on March 3, 2015 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter. /s/ Brian Keane, Attorney-in-Fact 2014-03-05